caprotec' scientific advisory consists of distinguished, interdisciplinary, and independent scientists from prominent research institutions worldwide.
Members of caprotec's scientific advisory board:
Hubert Köster, Ph.D.
(Founder, Acting CSO and Chairman of Scientific Advisory Board of caprotec™ bioanalytics GmbH)
Ira Goldfine, M.D.
(President, American Diabetes Association, Western Chapter; Professor of Medicine and Physiology, University of California at San Francisco); Expert in diabetes, endocrinology, and cancer. Cloned the insulin receptor and determined its role in breast cancer.
Franz Hillenkamp, Ph.D.
(Professor and Director Emeritus, Institute of Medical Physics and Biophysics at University of Münster, Germany; Visiting Professor, Harvard Medical School); Co-invented MALDI-TOF MS, now a ubiquitous tool for biomolecule analysis in the life sciences.
Joseph A. Loo, Ph.D.
(Professor of Biological Chemistry and Biochemistry, UCLA); Expert on uses of MS in biomedical research; previously Group Leader for biological MS and co-leader of Proteomics Division at Parke-Davis Pharmaceuticals (now Pfizer) from 1992-2001.
Sir John Walker, D. Phil.
(Dir., MRC's Dunn Human Nutrition Unit Cambridge, UK). Expert in membrane proteins and chemistry-based approaches to study proteins; 1997 Nobel Prize in Chemistry for elucidation of the enzymatic mechanism for ATP synthesis.
Ernst Mutschler, Ph.D.,MD
(Professor and Director Emeritus, Institute of Pharmacology at University of Frankfurt/Main, Germany); worldwide recognized expert in pharmacology, toxicology and drug development; author of numerous publications and patents and author of internationally recognized textbooks in pharmacology and drug actions.